T 1673/11 (Treatment of Pompe's disease/GENZYME) of 20.10.2015
- European Case Law Identifier
- ECLI:EP:BA:2015:T167311.20151020
- Date of decision
- 20 October 2015
- Case number
- T 1673/11
- Petition for review of
- -
- Application number
- 99965162.3
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- TREATMENT OF POMPE'S DISEASE
- Applicant name
- Genzyme Corporation
- Opponent name
- ZyStor Therapeutics , Inc.
Lingner, Margrit - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 112(1)(a)European Patent Convention Art 123(3)European Patent Convention Art 54(5)European Patent Convention Art 64(2)
- Keywords
- Article 123(3) EPC: Change from a claim under the provisions of the EPC 1973 invoking the legal fiction according to G 5/83to a claim under the provisions of Article 54(5) EPC 2000 (not allowable)
- Catchword
- -
- Cited cases
- G 0005/83G 0002/88G 0002/08T 0402/89T 0250/05T 0795/06T 0547/08T 1635/09T 0879/12T 1780/12
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.
3. The request for the referral of questions to the Enlarged Board of Appeal is refused.